Učitavanje...
Screening the genome for HCC-specific CpG methylation signatures as biomarkers for diagnosis and prognosis evaluation
BACKGROUND: Hepatocellular carcinoma (HCC) is one of the most common and invasive malignant tumors in the world. The change in DNA methylation is a key event in HCC. METHODS: Methylation datasets for HCC and 17 other types of cancer were downloaded from The Cancer Genome Atlas (TCGA). The CpG sites...
Spremljeno u:
| Izdano u: | BMC Med Genomics |
|---|---|
| Glavni autori: | , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
BioMed Central
2021
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8214801/ https://ncbi.nlm.nih.gov/pubmed/34147096 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12920-021-01015-9 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|